VOICED : Reino Unido primer país que aprueba píldora contra el covid-19 de Merck

The UK has approved Molnupiravir, an oral COVID-19 treatment by Merck, marking the first global approval of an antiviral that can be taken at home. This approval is significant for vulnerable and immunocompromised individuals. The drug is authorized for those with mild to moderate COVID-19 and at least one risk factor for severe disease. Molnupiravir serves a dual purpose: preventing severe symptoms in infected individuals and preventing disease development in close contacts. Clinical trials indicate a 50% reduction in hospitalization when administered shortly after a positive test.

What new insight or understanding did you gain from this video?